SCHEMBL14280213

SCHEMBL14280213

Nc1ccc(N)c(N2CCOCC2)c1

nearest known ligand 0.71

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
LGMN Q99538 5/20 0.71
MAPT P10636 6/20 0.66
GAA P10253 5/20 0.66
SMN1; SMN2 Q16637 3/20 0.66
ALDH1A1 P00352 3/20 0.51
MEN1 O00255 3/20 0.51
KMT2A Q03164 3/20 0.51
L3MBTL1 Q9Y468 2/20 0.51
RECQL P46063 2/20 0.51
POLB P06746 2/20 0.51
THRB P10828 1/20 0.51
BLM P54132 1/20 0.51
KDM4E B2RXH2 3/20 0.50
LMNA P02545 2/20 0.50
NPC1 O15118 2/20 0.46
RAB9A P51151 1/20 0.46
MAPK1 P28482 2/20 0.46
HTT P42858 2/20 0.46
S100B P04271 1/20 0.46
PKM P14618 1/20 0.46

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Sulfuric Acid SCHEMBL7807204 0.90 LGMN (0.59) LGMNMAPTGAASMN1; SMN2ALDH1A1
SCHEMBL7513264 0.86 MAPT (0.55) LGMNMAPTGAASMN1; SMN2ALDH1A1
SCHEMBL31491393 0.85 MAPT (0.71) LGMNMAPTGAASMN1; SMN2ALDH1A1
SCHEMBL4377045 0.85 MAPT (0.71) LGMNMAPTGAASMN1; SMN2ALDH1A1
SCHEMBL22716931 0.83 LGMN (1.00) LGMNMAPTGAASMN1; SMN2ALDH1A1
SCHEMBL24507284 0.81 MAPT (0.77) LGMNMAPTGAASMN1; SMN2ALDH1A1
SCHEMBL5825846 0.81 LGMN (0.67) LGMNMAPTGAASMN1; SMN2ALDH1A1
SCHEMBL923404 0.81 MAPT (0.62) LGMNMAPTGAASMN1; SMN2ALDH1A1
SCHEMBL520787 0.81 MAPT (0.62) LGMNMAPTGAASMN1; SMN2ALDH1A1
SCHEMBL27037134 0.81 LGMN (0.67) LGMNMAPTGAASMN1; SMN2ALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2008031594-A1 BENZOXAZOLES AND OXAZOLOPYRIDINES BEING USEFUL AS JANUS KINASES INHIBITORS NOVARTIS AG (CH) 2008-03-20 WO disclosed